Gentianella acuta prevents acute myocardial infarction induced by isoproterenol in rats via inhibition of galectin-3/TLR4/MyD88/NF-кB inflammatory signalling.

Gentianella acuta (G. acuta), as a folk medicine, was used to treat heart disease by the Ewenki people in Inner Mongolia. However, the effect of G. acuta on acute myocardial infarction (AMI) is not clear. To explore the mechanisms of G. acuta on isoproterenol (ISO)-induced AMI, rats were administered G. acuta for 28 days, then injected intraperitoneally with ISO (85 mg/kg) on days 29 and 30. An electrocardiogram helped to evaluate the myocardial injury. Serum lactate dehydrogenase (LDH), creatinine kinase (CK) and aspartate aminotransferase (AST) levels were evaluated, and haematoxylin eosin, Masson's trichrome staining and terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) staining were used to detect myocardial histological changes. Radioimmunoassay was used to measure serum tumour necrosis factor alpha (TNFα) and interleukin (IL)-6. An enzyme-linked immunosorbent assay kit was used to analyse serum galectin-3 (Gal-3) levels. Immunohistochemistry, Western blotting and reverse transcription polymerase chain reaction were used to examine relevant molecular events. The results revealed that pre-treatment with G. acuta decreased the elevation in the ST segment; reduced serum LDH, CK and AST levels; alleviated cardiac structure disorder; and reduced inflammatory infiltration, abnormal collagen deposition and cardiomyocyte apoptosis that were induced by ISO. Furthermore, pre-treatment with G. acuta inhibited serum Gal-3 levels and Gal-3 expression in heart tissue, and also impeded TLR4/MyD88/NF-кB signalling activation, which ultimately prevented the expression of inflammatory cytokines. The study indicated that pre-treatment with G. acuta protects against ISO-induced AMI, and the protective role may be related to inhibiting Gal-3/TLR4/MyD88/NF-кB inflammatory signalling.

Effects of an Integrated Neurofeedback System with Dry Electrodes: EEG Acquisition and Cognition Assessment.

Electroencephalogram (EEG) neurofeedback improves cognitive capacity and behaviors by regulating brain activity, which can lead to cognitive enhancement in healthy people and better rehabilitation in patients. The increased use of EEG neurofeedback highlights the urgent need to reduce the discomfort and preparation time and increase the stability and simplicity of the system's operation. Based on brain-computer interface technology and a multithreading design, we describe a neurofeedback system with an integrated design that incorporates wearable, multichannel, dry electrode EEG acquisition equipment and cognitive function assessment. Then, we evaluated the effectiveness of the system in a single-blind control experiment in healthy people, who increased the alpha frequency band power in a neurofeedback protocol. We found that upregulation of the alpha power density improved working memory following short-term training (only five training sessions in a week), while the attention network regulation may be related to other frequency band activities, such as theta and beta. Our integrated system will be an effective neurofeedback training and cognitive function assessment system for personal and clinical use.